Bind to opioid receptors to produce analgesia and euphoria. e.g., morphine, heroin, fentanyl.
Opioids
Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organisation staff
Background Many people who could benefit from medications for opioid use disorder (MOUD) aren’t receiving them. This study looks at how MOUD agencies in Kentucky are experiencing changes in patient numbers and the challenges and supports...
European Drugs Summer School (EDSS) 2025
Illicit drugs in Europe: demand, supply and public policies
Special Focus on Synthetic Opioids
Our two week in-person Summer School (23rd of June to 04th of July 2025) prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs. Teaching staff include scientific experts from the EUDA, researchers, practitioners and policymakers.
VCU researchers are developing a long-acting medication for opioid addiction
Researchers at Virginia Commonwealth University (VCU) have developed a new version of a medication for opioid use disorder that could offer longer-lasting treatment. Current medications for opioid addiction often require daily doses, but...
Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder
Background The opioid epidemic in the U.S. contributes to increased morbidity and mortality from drug overdoses, but barriers to traditional opioid use disorder (OUD) treatment limit access to care. During the COVID-19 pandemic, Public...
Substance Use Monitoring and Surveillance: Challenges faced by LMICs
Substance use surveillance has emerged as a crucial public health strategy across Africa, particularly in light of the alarming rise in substance use among adolescents (1). This trend poses significant health risks that require a...
